Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Jovelet · SciRah

Researcher profile · Semantic Scholar

C. Jovelet

Share profile

C. Jovelet — researcher profile on SciRah

h-index: 15
Works: 65
Citations: 1,123

Most-cited papers

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
F. Mosele, B. Stefanovska, A. Lusque, A. T. Dien +18 more
2020Annals of Oncology272 citations Open access
Semantic Scholar
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA
J. Remon, C. Caramella, C. Jovelet, L. Lacroix +15 more
2017Annals of Oncology169 citations Open access
Semantic Scholar
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
C. Jovelet, E. Ileana, M. le Deley, N. Motté +21 more
2016Clinical Cancer Research102 citations
Semantic Scholar
Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
Florence Koeppel, S. Blanchard, C. Jovelet, B. Génin +7 more
2017PLoS ONE98 citations Open access
Semantic Scholar
Circulating tumor DNA analysis for oncogene-addicted non-small cell lung cancer patients with isolated central nervous system progression.
M. Aldea, L. Hendriks, L. Mezquita, C. Jovelet +18 more
2019Journal of Thoracic Oncology61 citations Open access
Semantic Scholar
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer.
L. Mezquita, A. Swalduz, C. Jovelet, S. Ortiz-Cuàran +26 more
2020JCO Precision Oncology53 citations Open access
Semantic Scholar
Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer
J. Remon, L. Lacroix, C. Jovelet, C. Caramella +17 more
2019JCO Precision Oncology48 citations Open access
Semantic Scholar
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
J. Madic, C. Jovelet, Julien Lopez, B. André +7 more
2018OncoTarget42 citations Open access
Semantic Scholar
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non–Small Cell Lung Cancer
S. Ortiz-Cuàran, L. Mezquita, A. Swalduz, Miha Aldea +31 more
2020Clinical Cancer Research39 citations
Semantic Scholar
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
C. Jovelet, J. Madic, J. Remon, A. Honoré +6 more
2017PLoS ONE31 citations Open access
Semantic Scholar
Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
C. Jovelet, J. Bénard, F. Forestier, Robert Farinotti +2 more
2012European Journal of Pharmaceutical Sciences31 citations
Semantic Scholar
Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model.
C. Jovelet, A. Seck, O. Mir, C. Simasotchi +5 more
2015Annals of Oncology27 citations Open access
Semantic Scholar
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
D. Enrico, L. Lacroix, Jeanne K. Chen, E. Rouleau +18 more
2020JTO Clinical and Research Reports22 citations Open access
Semantic Scholar
Development of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendations.
J. Denis, J. Nectoux, P. Lamy, Christelle Rouillac Le Sciellour +9 more
2018Annales de Biologie Clinique17 citations
Semantic Scholar
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
J. Remon, A. Swalduz, D. Planchard, S. Ortiz-Cuàran +14 more
2020PLoS ONE16 citations Open access
Semantic Scholar
Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations.
Yu Fu, C. Jovelet, T. Filleron, Marion Pedrero +13 more
2016Cancer Research14 citations Open access
Semantic Scholar
Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib
C. Jovelet, Alain Deroussent, S. Broutin, A. Paci +3 more
2013European journal of drug metabolism and pharmacokinetics12 citations
Semantic Scholar
6-Color Crystal Digital PCRTM for the High-Plex Detection of EGFR Mutations in Non-Small Cell Lung Cancer.
J. Madic, C. Jovelet, Imane Dehri, A. Mallory
2021Methods in molecular biology7 citations
Semantic Scholar
Evaluation of liquid biopsies for molecular profiling in untreated patients with stage III/IV non-small cell lung cancer (NSCLC).
B. Besse, J. Remon, L. Lacroix, L. Mezquita +8 more
20177 citations
Semantic Scholar
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer
A. Géraud, L. Mezquita, É. Auclin, D. Combarel +16 more
2020Cancers5 citations Open access
Semantic Scholar
Clinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC
L. Mezquita, D. Planchard, M. Suarez, M. Aldea +16 more
2019Annals of Oncology5 citations Open access
Semantic Scholar
Multiple synchronous mechanisms may contribute to osimertinib resistance in non-small cell lung cancer (NSCLC) patients: Insights of the MATCH-R study
D. Enrico, L. Lacroix, E. Rouleau, J. Scoazec +16 more
2019Annals of Oncology5 citations Open access
Semantic Scholar
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
J. Madic, C. Jovelet, Julien Lopez, B. André +7 more
2019OncoTarget5 citations Open access
Semantic Scholar
MA21.07 Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
S. Ortiz-Cuàran, L. Mezquita, A. Swalduz, M. Aldea +30 more
2019Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
Abstract 2401: Circulating cell-free tumor DNA (cfDNA) analysis of 50-genes by next-generation sequencing (NGS) in the prospective MOSCATO trial
E. Ileana, C. Jovelet, M. le Deley, C. Massard +21 more
20154 citations
Semantic Scholar
MA21.09 Tyrosine Kinase Inhibitors' Plasma Concentration and Oncogene-Addicted Advanced Non-Small Lung Cancer (aNSCLC) Resistance
A. Géraud, L. Mezquita, É. Auclin, D. Combarel +12 more
2019Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
Abstract 4581: Feasibility of an amplicon-based liquid biopsy forALKandROS1fusions in advanced non-small cell lung cancer (NSCLC) patients
L. Mezquita, Yue-Bi Hu, K. Howarth, C. Jovelet +18 more
2018Clinical research3 citations
Semantic Scholar
Abstract 3192: Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer patients lacking tissue samples
J. Remon, J. Soria, D. Planchard, C. Jovelet +13 more
20163 citations
Semantic Scholar
Circulating tumour DNA (ctDNA) analysis depicts mechanisms of resistance and tumour response to BRAF inhibitors in BRAF-mutant non-small cell lung cancer (NSCLC)
S. Ortiz-Cuàran, L. Mezquita, A. Swalduz, M. Aldea +16 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
L. Mezquita, C. Jovelet, L. Lacroix, D. Planchard +15 more
20182 citations
Semantic Scholar
118PNationwide external quality assessment (EQA) of EGFR testing in circulating tumor DNA: The French experience
M. Denis, A. Vallée, S. Charpentier, I. Nanni-Metellus +6 more
20172 citations Open access
Semantic Scholar
1090P HER2 copy number variation in non-small cell lung cancer (NSCLC)
M. Tagliamento, É. Auclin, A. Valent, R. Ferrara +14 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
Abstract 75: Highly multiplexed EGFR mutation detection from liquid biopsy samples using the 6-color Crystal Digital PCR™
C. Jovelet, Myrtille Remy, N. Pata-Merci, D. Vasseur +3 more
2022Cancer Research1 citations
Semantic Scholar
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer.
M. Riudavets, V. Lamberts, D. Vasseur, É. Auclin +15 more
2022Clinical Lung Cancer1 citations Open access
Semantic Scholar
Minimal residual disease (MRD) in patients with resected stage I NSCLC: Results of the prospective adjuvant IFCT-0703 trial.
D. Vasseur, C. Jovelet, N. Cozic, J. Mazières +15 more
20211 citations
Semantic Scholar
1267P Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
M. Melià, D. Vasseur, M. Aldea, V. Lamberts +16 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
22P Clinical utility of ddPCR for detection of sensitizing and resistance EGFRm in pts with advanced NSCLC
M. Riudavets, V. Lamberts, É. Auclin, M. Aldea +14 more
20211 citations
Semantic Scholar
Efficacy of tyrosine kinase inhibitors (TKIs) based on the ALK resistance mutations on amplicon-based liquid biopsy in ALK positive non-small cell lung cancer (NSCLC) patients (pts).
L. Mezquita, A. Swalduz, C. Jovelet, S. Ortiz-Cuàran +16 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Plasma circulating tumor DNA analysis (ctDNA) for molecular alteration detection in advanced non-small cell lung cancer (NSCLC) patients (pts) with isolated central nervous system (CNS) metastases (mts).
M. Aldea, L. Hendriks, L. Mezquita, J. Remon-Masip +12 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
P1.01-67 Clinical Relevance of ALK/ROS1 Resistance Mutations and Other Acquired Mutations Detected by Liquid Biopsy in Advanced NSCLC Patients
L. Mezquita, A. Swalduz, C. Jovelet, S. Ortiz-Cuàran +19 more
2018Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
MA16.09 Feasibility, Clinical Relevance of ALK/ROS1 Fusion Variant Detection by Liquid Biopsy in Advanced Non-Small Cell Lung Cancer
A. Swalduz, L. Mezquita, S. Ortiz-Cuàran, C. Jovelet +20 more
2018Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Evaluation of liquid biopsies for molecular profiling in patients with advanced non-small cell lung cancer (NSCLC) in the relapse treatment setting.
J. Remon, B. Besse, L. Lacroix, L. Mezquita +8 more
20171 citations
Semantic Scholar
P1.03-013 Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
L. Mezquita, J. Remon, C. Nicotra, M. Noerholm +15 more
20171 citations Open access
Semantic Scholar
Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients.
J. Remon, J. Soria, L. Lacroix, K. Howarth +9 more
20161 citations
Semantic Scholar
A multiplex droplet digital PCR assay for chromosome copy-number determination in Candida albicans
Eli I. Maciel, Sylvain Ursuegui, Sana Ahmed‐Seghir, C. Maufrais +6 more
2026bioRxiv0 citations Open access
Semantic Scholar
110P 13-plex non-invasive genotyping in HPV related cancers in the MOSCATO trial
E. Rupp, R. Hajri, A. Rathakrishnan, G. Jardali +11 more
2024Annals of Oncology0 citations
Semantic Scholar
Abstract 6701: 6-color Crystal Digital PCR for the high-plex detection of 10 ESR1 mutations in breast cancer
S. Smilkou, A. Ntzifa, D. Stergiopoulou, Quentin Blache +4 more
2023Cancer Research0 citations
Semantic Scholar
Abstract 2942: Robust sample recovery post-digital PCR for downstream genomic applications
K. Gutierrez, Benjamin Foret, C. Jovelet, A. Mallory
2022Cancer Research0 citations
Semantic Scholar
Abstract 527: A streamlined workflow for liquid biopsy extraction and highplex digital PCR analysis using the Maxwell® RSC system and 6-color Crystal Digital PCR™
C. Jovelet, Myrtille Remy, Mylène Menanteau, Doug White +2 more
2022Cancer Research0 citations
Semantic Scholar
Abstract 534: An ultrasensitive high-plex assay detecting 24 PIK3CA mutations using SAGAsafe® technology and 6-color Crystal Digital PCR™
M. Alcaide, A. George, Yi-Lun Chen, C. Jovelet +3 more
2022Cancer Research0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Lacroix×38
Invite
L. Lacroix — researcher profile on SciRah
B. Besse×32
Invite
B. Besse — researcher profile on SciRah
L. Mezquita×26
Invite
L. Mezquita — researcher profile on SciRah
D. Planchard×25
Invite
D. Planchard — researcher profile on SciRah

×19

Invite

E. Green — researcher profile on SciRah

Invite

C. Morris — researcher profile on SciRah

Invite

E. Rouleau — researcher profile on SciRah

Invite

J. Remon — researcher profile on SciRah

Invite

K. Howarth — researcher profile on SciRah

Invite

J. Soria — researcher profile on SciRah

C. Caramella×13

Invite

C. Caramella — researcher profile on SciRah

Invite

A. Gazzah — researcher profile on SciRah